Pictet Asset Management (Switzerland)’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $10.3M | Buy |
1,565,209
+347,392
| +29% | +$2.29M | 0.01% | 613 |
|
|
2023
Q1 | $8.27M | Buy |
1,217,817
+761,200
| +167% | +$5.17M | 0.01% | 655 |
|
|
2022
Q4 | $3.37M | Buy |
456,617
+113,627
| +33% | +$840K | ﹤0.01% | 827 |
|
|
2022
Q3 | $3.39M | Buy |
342,990
+58,601
| +21% | +$579K | 0.01% | 814 |
|
|
2022
Q2 | $3.1M | Buy |
284,389
+65,207
| +30% | +$711K | ﹤0.01% | 856 |
|
|
2022
Q1 | $2.48M | Hold |
219,182
| – | – | ﹤0.01% | 933 |
|
|
2021
Q4 | $3.44M | Sell |
219,182
-28,454
| -11% | -$446K | ﹤0.01% | 903 |
|
|
2021
Q3 | $4.24M | Buy |
+247,636
| New | +$4.24M | ﹤0.01% | 864 |
|